nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.214	0.251	CbGbCtD
Trazodone—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.214	0.251	CbGbCtD
Trazodone—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.16	0.188	CbGbCtD
Trazodone—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.104	0.122	CbGbCtD
Trazodone—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0983	0.115	CbGbCtD
Trazodone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0625	0.0733	CbGbCtD
Trazodone—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0076	0.372	CbGeAlD
Trazodone—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.0374	CcSEcCtD
Trazodone—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00446	0.0356	CcSEcCtD
Trazodone—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00435	0.0348	CcSEcCtD
Trazodone—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0344	CcSEcCtD
Trazodone—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00416	0.0332	CcSEcCtD
Trazodone—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.0322	CcSEcCtD
Trazodone—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.0266	CcSEcCtD
Trazodone—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.0233	CcSEcCtD
Trazodone—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.0225	CcSEcCtD
Trazodone—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.0222	CcSEcCtD
Trazodone—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.0212	CcSEcCtD
Trazodone—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.0195	CcSEcCtD
Trazodone—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.0195	CcSEcCtD
Trazodone—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0175	CcSEcCtD
Trazodone—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00213	0.104	CbGeAlD
Trazodone—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.0167	CcSEcCtD
Trazodone—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.0164	CcSEcCtD
Trazodone—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.0164	CcSEcCtD
Trazodone—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.0163	CcSEcCtD
Trazodone—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.0158	CcSEcCtD
Trazodone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.0156	CcSEcCtD
Trazodone—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.0155	CcSEcCtD
Trazodone—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.015	CcSEcCtD
Trazodone—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.0146	CcSEcCtD
Trazodone—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00182	0.0891	CbGeAlD
Trazodone—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.0144	CcSEcCtD
Trazodone—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00156	0.0763	CbGeAlD
Trazodone—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0122	CcSEcCtD
Trazodone—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0117	CcSEcCtD
Trazodone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0115	CcSEcCtD
Trazodone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0115	CcSEcCtD
Trazodone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.0111	CcSEcCtD
Trazodone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0111	CcSEcCtD
Trazodone—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.011	CcSEcCtD
Trazodone—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0108	CcSEcCtD
Trazodone—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0101	CcSEcCtD
Trazodone—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00978	CcSEcCtD
Trazodone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00946	CcSEcCtD
Trazodone—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00942	CcSEcCtD
Trazodone—HTR2B—cortex of kidney—focal segmental glomerulosclerosis	0.00114	0.056	CbGeAlD
Trazodone—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00911	CcSEcCtD
Trazodone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00907	CcSEcCtD
Trazodone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00897	CcSEcCtD
Trazodone—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00871	CcSEcCtD
Trazodone—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00867	CcSEcCtD
Trazodone—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00865	CcSEcCtD
Trazodone—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00858	CcSEcCtD
Trazodone—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00833	CcSEcCtD
Trazodone—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00828	CcSEcCtD
Trazodone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0082	CcSEcCtD
Trazodone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00817	CcSEcCtD
Trazodone—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00812	CcSEcCtD
Trazodone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000997	0.00797	CcSEcCtD
Trazodone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000994	0.00794	CcSEcCtD
Trazodone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000955	0.00763	CcSEcCtD
Trazodone—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000942	0.00752	CcSEcCtD
Trazodone—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000942	0.00752	CcSEcCtD
Trazodone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000942	0.00752	CcSEcCtD
Trazodone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000938	0.0075	CcSEcCtD
Trazodone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00093	0.00743	CcSEcCtD
Trazodone—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000921	0.00736	CcSEcCtD
Trazodone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00091	0.00727	CcSEcCtD
Trazodone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000903	0.00721	CcSEcCtD
Trazodone—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000881	0.0431	CbGeAlD
Trazodone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000873	0.00697	CcSEcCtD
Trazodone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00086	0.00687	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000822	0.00657	CcSEcCtD
Trazodone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000816	0.00652	CcSEcCtD
Trazodone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000811	0.00648	CcSEcCtD
Trazodone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000805	0.00643	CcSEcCtD
Trazodone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000803	0.00641	CcSEcCtD
Trazodone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000785	0.00627	CcSEcCtD
Trazodone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000778	0.00622	CcSEcCtD
Trazodone—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000774	0.0379	CbGeAlD
Trazodone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000772	0.00617	CcSEcCtD
Trazodone—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000772	0.00617	CcSEcCtD
Trazodone—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000754	0.0369	CbGeAlD
Trazodone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00594	CcSEcCtD
Trazodone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000738	0.0059	CcSEcCtD
Trazodone—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.000719	0.0352	CbGeAlD
Trazodone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000717	0.00573	CcSEcCtD
Trazodone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000714	0.0057	CcSEcCtD
Trazodone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000714	0.0057	CcSEcCtD
Trazodone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000665	0.00531	CcSEcCtD
Trazodone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000648	0.00517	CcSEcCtD
Trazodone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000639	0.0051	CcSEcCtD
Trazodone—HTR2A—kidney—focal segmental glomerulosclerosis	0.000628	0.0307	CbGeAlD
Trazodone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000618	0.00493	CcSEcCtD
Trazodone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.00477	CcSEcCtD
Trazodone—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000581	0.0284	CbGeAlD
Trazodone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000574	0.00458	CcSEcCtD
Trazodone—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000572	0.028	CbGeAlD
Trazodone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000569	0.00455	CcSEcCtD
Trazodone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000569	0.00454	CcSEcCtD
Trazodone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000566	0.00452	CcSEcCtD
Trazodone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000536	0.00428	CcSEcCtD
Trazodone—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000468	0.0229	CbGeAlD
Trazodone—ABCB1—kidney—focal segmental glomerulosclerosis	0.000411	0.0201	CbGeAlD
Trazodone—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000401	0.0196	CbGeAlD
Trazodone—HTR2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	2.85e-06	0.002	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.8e-06	0.00197	CbGpPWpGaD
Trazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	2.76e-06	0.00194	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	2.76e-06	0.00194	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	2.72e-06	0.00191	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	2.72e-06	0.00191	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	2.7e-06	0.0019	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	2.66e-06	0.00187	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	2.64e-06	0.00185	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2.56e-06	0.0018	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	2.55e-06	0.00179	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	2.55e-06	0.00179	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2.54e-06	0.00179	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	2.54e-06	0.00179	CbGpPWpGaD
Trazodone—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	2.54e-06	0.00178	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	2.53e-06	0.00178	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	2.53e-06	0.00178	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	2.53e-06	0.00178	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	2.51e-06	0.00176	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	2.48e-06	0.00174	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	2.43e-06	0.00171	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	2.42e-06	0.0017	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	2.41e-06	0.00169	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.4e-06	0.00169	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	2.39e-06	0.00168	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.39e-06	0.00168	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	2.32e-06	0.00163	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	2.31e-06	0.00162	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	2.31e-06	0.00162	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	2.31e-06	0.00162	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	2.3e-06	0.00162	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	2.3e-06	0.00161	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2.21e-06	0.00155	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	2.21e-06	0.00155	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2.2e-06	0.00155	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	2.2e-06	0.00154	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	2.2e-06	0.00154	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	2.19e-06	0.00154	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	2.19e-06	0.00154	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2.16e-06	0.00152	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	2.15e-06	0.00151	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	2.14e-06	0.0015	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	2.13e-06	0.00149	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	2.1e-06	0.00148	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	2.1e-06	0.00147	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.08e-06	0.00146	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.07e-06	0.00145	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	2.06e-06	0.00145	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	2.04e-06	0.00144	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.03e-06	0.00143	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2.01e-06	0.00141	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	2.01e-06	0.00141	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	2e-06	0.00141	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	2e-06	0.0014	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.99e-06	0.0014	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.99e-06	0.0014	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.96e-06	0.00138	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.96e-06	0.00137	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.95e-06	0.00137	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.94e-06	0.00137	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.94e-06	0.00136	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.93e-06	0.00136	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	1.91e-06	0.00134	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.91e-06	0.00134	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.9e-06	0.00134	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.9e-06	0.00134	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	1.89e-06	0.00133	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.87e-06	0.00131	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.87e-06	0.00131	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.86e-06	0.0013	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.86e-06	0.0013	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.85e-06	0.0013	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.84e-06	0.00129	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.83e-06	0.00128	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.81e-06	0.00127	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.81e-06	0.00127	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.78e-06	0.00125	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.77e-06	0.00124	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.74e-06	0.00122	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.7e-06	0.00119	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.69e-06	0.00119	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.69e-06	0.00119	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.69e-06	0.00118	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.68e-06	0.00118	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.68e-06	0.00118	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.68e-06	0.00118	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.68e-06	0.00118	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.67e-06	0.00118	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.66e-06	0.00116	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.65e-06	0.00116	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.65e-06	0.00116	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.64e-06	0.00115	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.61e-06	0.00113	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.61e-06	0.00113	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.61e-06	0.00113	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	1.58e-06	0.00111	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.58e-06	0.00111	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.56e-06	0.0011	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.54e-06	0.00108	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.54e-06	0.00108	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.53e-06	0.00108	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.53e-06	0.00107	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.53e-06	0.00107	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.51e-06	0.00106	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.5e-06	0.00105	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.5e-06	0.00105	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.48e-06	0.00104	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.47e-06	0.00103	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.43e-06	0.00101	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.43e-06	0.001	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.41e-06	0.000993	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.4e-06	0.000985	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.4e-06	0.00098	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.38e-06	0.000966	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.37e-06	0.000963	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.37e-06	0.000961	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.37e-06	0.00096	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.36e-06	0.000959	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.36e-06	0.000958	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.36e-06	0.000953	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	1.33e-06	0.000933	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.32e-06	0.000924	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	1.31e-06	0.000922	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.3e-06	0.000915	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.3e-06	0.000913	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.3e-06	0.000911	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.29e-06	0.000908	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.27e-06	0.000894	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.25e-06	0.000879	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.25e-06	0.000877	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.24e-06	0.000873	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	1.22e-06	0.000855	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.19e-06	0.000835	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.19e-06	0.000833	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.19e-06	0.000832	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.18e-06	0.000831	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.18e-06	0.000831	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.18e-06	0.000828	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.18e-06	0.000826	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	1.17e-06	0.000822	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.16e-06	0.000817	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.16e-06	0.000815	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.15e-06	0.00081	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.15e-06	0.000805	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.14e-06	0.000801	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.1e-06	0.00077	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.08e-06	0.000759	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.08e-06	0.000758	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.08e-06	0.000757	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.08e-06	0.000757	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.08e-06	0.000756	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	1.07e-06	0.000753	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.07e-06	0.000753	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.06e-06	0.000747	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.06e-06	0.000742	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.05e-06	0.000737	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.04e-06	0.000733	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	1.03e-06	0.000722	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.01e-06	0.000708	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.91e-07	0.000696	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.88e-07	0.000694	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.88e-07	0.000694	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.82e-07	0.00069	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.7e-07	0.000681	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	9.19e-07	0.000645	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.1e-07	0.000639	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.06e-07	0.000636	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.04e-07	0.000635	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.01e-07	0.000633	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.89e-07	0.000624	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.87e-07	0.000623	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.85e-07	0.000621	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	8.79e-07	0.000618	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	8.66e-07	0.000608	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.63e-07	0.000606	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.58e-07	0.000603	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.41e-07	0.000591	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	8.3e-07	0.000583	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.24e-07	0.000579	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.17e-07	0.000574	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.13e-07	0.000571	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	8.11e-07	0.00057	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	8.09e-07	0.000568	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.86e-07	0.000552	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.68e-07	0.00054	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.66e-07	0.000538	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	7.62e-07	0.000535	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.52e-07	0.000528	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.45e-07	0.000523	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.45e-07	0.000523	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.44e-07	0.000522	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	7.43e-07	0.000522	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.38e-07	0.000518	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.34e-07	0.000516	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.3e-07	0.000513	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.06e-07	0.000496	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.04e-07	0.000495	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.02e-07	0.000493	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7e-07	0.000491	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.99e-07	0.000491	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	6.94e-07	0.000487	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.91e-07	0.000485	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.82e-07	0.000479	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.78e-07	0.000476	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.78e-07	0.000476	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	6.75e-07	0.000474	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.42e-07	0.000451	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.38e-07	0.000448	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.36e-07	0.000447	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	6.36e-07	0.000446	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.24e-07	0.000438	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.89e-07	0.000414	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.88e-07	0.000413	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.8e-07	0.000407	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.77e-07	0.000405	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.67e-07	0.000399	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	5.66e-07	0.000398	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.65e-07	0.000396	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	5.61e-07	0.000394	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.36e-07	0.000376	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.36e-07	0.000376	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	5.32e-07	0.000374	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	5.28e-07	0.000371	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.98e-07	0.00035	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.9e-07	0.000344	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.89e-07	0.000344	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	4.88e-07	0.000343	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.8e-07	0.000337	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	4.8e-07	0.000337	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.59e-07	0.000323	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	4.52e-07	0.000317	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.46e-07	0.000313	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.42e-07	0.00031	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.35e-07	0.000305	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.32e-07	0.000304	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.75e-07	0.000264	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.75e-07	0.000263	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3.68e-07	0.000259	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.68e-07	0.000258	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.58e-07	0.000252	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.56e-07	0.00025	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	3.47e-07	0.000244	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	3.45e-07	0.000243	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.42e-07	0.00024	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.09e-07	0.000217	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.09e-07	0.000217	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.03e-07	0.000213	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.96e-07	0.000208	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.82e-07	0.000198	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	2.27e-07	0.000159	CbGpPWpGaD
